These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35510521)

  • 1. Liver injury and cytopenia after BNT162b2 COVID-19 vaccination in an adolescent.
    Kawasaki Y; Matsubara K; Hori M; Isome K
    Pediatr Int; 2022 Jan; 64(1):e15178. PubMed ID: 35510521
    [No Abstract]   [Full Text] [Related]  

  • 2. New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Kobayashi M; Mori A; Oda Y; Yokoyama E; Kanaya M; Izumiyama K; Saito M; Tanaka S; Morioka M; Kondo T
    Int J Hematol; 2023 Oct; 118(4):477-482. PubMed ID: 37219678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia after COVID-19 vaccination.
    Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
    J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.
    Burn E; Roel E; Pistillo A; Fernández-Bertolín S; Aragón M; Raventós B; Reyes C; Verhamme K; Rijnbeek P; Li X; Strauss VY; Prieto-Alhambra D; Duarte-Salles T
    Nat Commun; 2022 Nov; 13(1):7169. PubMed ID: 36418321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous pneumomediastinum after BNT162b2 COVID-19 vaccination in adolescents.
    Lam CY; Chang L; Lin SM
    Pediatr Neonatol; 2023 Jul; 64(4):487-488. PubMed ID: 37012100
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study.
    Sing CW; Tang CTL; Chui CSL; Fan M; Lai FTT; Li X; Wan EYF; Wong CKH; Chan EWY; Hung IFN; Leung AY; Cheung CL; Wong ICK
    Am J Hematol; 2022 Apr; 97(4):470-480. PubMed ID: 35080247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
    Wong CKH; Mak LY; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng WY; Cheng FWT; Yuen MF; Wong ICK
    J Hepatol; 2022 Nov; 77(5):1339-1348. PubMed ID: 35817224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral response to mRNA-based COVID-19 vaccine in patients with de novo and pre-existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination.
    Mori A; Onozawa M; Kobayashi M; Tsukamoto S; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
    Br J Haematol; 2022 Nov; 199(4):627-630. PubMed ID: 36096497
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.
    Cari L; Fiore P; Naghavi Alhosseini M; Sava G; Nocentini G
    J Autoimmun; 2021 Aug; 122():102685. PubMed ID: 34174723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura.
    Wang SSY
    Postgrad Med J; 2022 Dec; 98(1166):900-901. PubMed ID: 35022253
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
    Dag Berild J; Bergstad Larsen V; Myrup Thiesson E; Lehtonen T; Grøsland M; Helgeland J; Wolhlfahrt J; Vinsløv Hansen J; Palmu AA; Hviid A
    JAMA Netw Open; 2022 Jun; 5(6):e2217375. PubMed ID: 35699955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audio Interview: Vaccinating Children.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jun; 384(22):e103. PubMed ID: 34077650
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
    Li X; Burn E; Duarte-Salles T; Yin C; Reich C; Delmestri A; Verhamme K; Rijnbeek P; Suchard MA; Li K; Mosseveld M; John LH; Mayer MA; Ramirez-Anguita JM; Cohet C; Strauss V; Prieto-Alhambra D
    BMJ; 2022 Oct; 379():e071594. PubMed ID: 36288813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine.
    Saito K; Shimizu T; Suzuki-Inoue K; Ishida T; Wada Y
    Neurol Sci; 2021 Nov; 42(11):4433-4435. PubMed ID: 34378098
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.
    Algaissi A; Alamer E; Jeraiby M; Alomaish A; Elrhima O; Qumayi S; Qasir NA; Areeshi H; Masmali A; Alhazmi A
    Saudi Med J; 2022 Jun; 43(6):567-571. PubMed ID: 35675927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.
    Gambichler T; Scholl L; Dickel H; Ocker L; Stranzenbach R
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e415-e416. PubMed ID: 33725406
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination.
    Fotiadou A; Tsiptsios D; Kitmeridou S; Mavraki E; Iliopoulos I
    Neurol Sci; 2023 Feb; 44(2):457-459. PubMed ID: 36326949
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
    Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
    J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.